Novel API Coated Catheter Removes Amyloid-β from Plasma of Patients with Alzheimer’s Disease

Alzheimer’s disease (AD) is the most common cause of dementia, characterized by the deposition of Amyloid-beta (Aβ) plaques in the brain. We have previously developed Amytrap peptide (the active pharmacological ingredient, API) and linked it to a sepharose bead matrix by click chemistry to form Amyt...

Descripción completa

Detalles Bibliográficos
Autores principales: Chhipa, Rishi Raj, Gandbhir, Omkar, Le, Hao, Sankar, Sadhana, Sundaram, Pazhani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612462/
https://www.ncbi.nlm.nih.gov/pubmed/34825129
http://dx.doi.org/10.24966/and-9608/100055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612462/
https://www.ncbi.nlm.nih.gov/pubmed/34825129
http://dx.doi.org/10.24966/and-9608/100055

Ejemplares similares